News
-
-
COMMUNIQUÉ DE PRESSE
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
enVVeno Medical presents positive topline efficacy data from the SAVVE U.S. pivotal trial for the VenoValve at the 2024 American Venous Forum Annual Meeting, showing significant clinical improvement in CVI patients -
COMMUNIQUÉ DE PRESSE
Neptune Announces Decision of Nasdaq Hearings Panel To Delist Common Shares
Neptune Wellness Solutions Inc. provides an update on the status of its appeal against Nasdaq's delisting determination for its Common Shares. The Company's shares to be suspended from Nasdaq, seeking quotation on OTCQB® Venture Market -
-
-
-
COMMUNIQUÉ DE PRESSE
Karbon-X Announces Appointment of Brett Hull and Justin Bourque to its Board of Directors
Karbon-X appoints Brett Hull and Justin Bourque to its Board of Directors, enhancing expertise in climate change strategies. The two renowned leaders bring sports management and Indigenous community relations experience -
-
COMMUNIQUÉ DE PRESSE
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
Bausch Health Companies Inc. and Salix Pharmaceuticals are supporting a Phase 2 study of RELISTOR in head and neck cancer patients. The study aims to evaluate the potential of methylnaltrexone bromide as a treatment option -
COMMUNIQUÉ DE PRESSE
Parade’s CoDriver Brings Generative AI to McLeod Software's PowerBroker TMS Users
Parade introduces Capacity CoDriver, a generative AI feature enhancing freight brokerage efficiency with instant carrier responses and increased digital quote volume. Integration with PowerBroker TMS sets new industry standard
